Interv Pain Med Neuromod
Interv Pain Med Neuromod

article information

Interventional Pain Medicine and Neuromodulation: Vol.1, issue 1; e115716
published online: July 7, 2021
article type: Editorial
received: May 13, 2021
accepted: May 25, 2021
DOI: https://doi.org/10.5812/ipmn.115716
Crossmark

Evolution of Interventional Pain Management and Its Barriers in Developing Countries

authors:

avatar Masoud Hashemi ORCID 1 , avatar Reza Aminnejad ORCID 2 , avatar Shima Rajaei ORCID 1 , *

Shahid Beheshti Medical University, Tehran, Iran
Qom University of Medical Sciences, Qom, Iran

how to cite: Hashemi M, Aminnejad R, Rajaei S. Evolution of Interventional Pain Management and Its Barriers in Developing Countries. Interv Pain Med Neuromod. 2021;1(1):e115716. https://doi.org/10.5812/ipmn.115716.

The history of interventional pain management techniques dates back to Koller’s invention of regional anesthesia in 1884 (1). Subsequently, regional anesthesia has developed into a distinct specialty using interventional techniques beyond simple neural blockade. In 1899, the first therapeutic nerve block in pain management was described by Tuffer (2) using spinal injection of cocaine to reduce leg sarcoma pain. Von Gaza (3) pioneered diagnostic block using procaine to determine the pathways of pain. In the twenty-first century, interventional pain management has entered the modern era with pioneers like Manchikanti et al. (4).

Although interventional pain management has progressed prominently, there are many inevitable differences in pain management strategies between developed and developing countries. Pain is often poorly controlled in developing countries (5). There are several reasons why pain of any type, is not adequately treated in these countries. The most important reasons are as follows:

1- Healthcare systems are not well developed. Pain management is less of a priority than diseases such as tuberculosis or AIDS. Low health care staff, misconceptions or outdated attitudes about pain management, insufficient knowledge about treatment choices are contributing factors (6).

2- Proper pain control needs appropriate assessment. There are various tools and questionnaires for assessing pain and planning a proper pain management protocol for each patient, which need to be allocated enough time to complete. A large number of patients and limited human resources do not provide sufficient time for physicians to adequately assess and appropriately manage pain, especially in chronic states (7).

3- Knowledge of caring nurses regarding pain management and adherence to established protocols are limited universally (8, 9). This shortcoming is more prevalent in developing countries.

4- Today, multidisciplinary approach to chronic pain management is a standard program to ensure good outcomes (10). Unfortunately, there are many reasons to limit this approach in developing countries.

5- In recent years, emerging drug therapies for chronic pain have been proposed and supported by communities, including the medical use of cannabis (11-13). But some cumbersome laws have prevented these new treatments from becoming common in developing countries.

6- In some cultures, pain tolerance may be seen as a sign of strength, or in labor, the presence of pain is considered necessary, which are proofs of the wrong attitude of some people toward pain management (14, 15).

7- Chronic pain patients’ expectations of pain management are low or inappropriate. For example, in cancer patients, most attention is paid to chemotherapy or radiotherapy, which deviates from the patient’s limited expectation of his/her pain treatment (7), or patients expect to be fully cured after one or two sessions, indicating patient’s inadequate knowledge of pain management (16).

8- The range of available analgesic medications in developing countries is limited, and they may not be available immediately (17). Access to opioid analgesics, in particular, is problematic. This is partly due to outdated and strict legal restrictions that prevent physicians from prescribing opioids (18, 19) Patient’s demand for these drugs is also reduced due to administrative barriers, fear of addiction or their high cost (20, 21). The World Health Organization (WHO) estimates that 5.5 billion people (more than 80% of the world population) do not have access to treatments for moderate to severe pain. Most of these people live in developing countries (22).

9- Most researches in developing countries are related to palliative care; acute pain and chronic non-cancer pain has received less attention (23).

10) Because the income level of most people in developing countries is moderate to low, patients cannot afford the cost of equipment such as spinal cord stimulation (SCS). Also, the replacement or repair of epidoroscopic or endoscopic instruments imposes a high cost on hospitals or physicians, and insurance refuses to pay these costs.

As can be seen, barriers to pain management in developing countries are significant and include insufficient knowledge and poor attitude about pain management, low priority of pain treatment and lack or difficulty access to analgesics, high cost of some instrument for advanced pain procedures. Education plays a key role in overcoming these barriers (5), and we must all work together to reach a global standard for patient pain management.

References

  • 1.

    Cousins MJ, Bridenbaugh PO, Carr DB, Horlocker TT. Cousins and Bridenbaugh's neural blockade in clinical anesthesia and pain medicine. Lippincott Williams & Wilkins; 2009.

  • 2.

    Tuffier T. Anesthesie medullaire chirurgicale par injection sous-arachnoidienne lombaire de cocaine; technique et resultats. Sem Med. 1900;20:167-9.

  • 3.

    Von Gaza W. Die Resektion der paravertebralen Nerven und die isolierte Durchschneidung des Ramus communicans. Arch Klin Chir. 1924;133:479.

  • 4.

    Manchikanti L, Boswell MV, Raj PP, Racz GB. Evolution of interventional pain management. Pain Physician. 2003;6(4):485-94. [PubMed ID: 16871301].

  • 5.

    Bond M. Pain education issues in developing countries and responses to them by the International Association for the Study of Pain. Pain Res Manag. 2011;15(5):404-6. https://doi.org/10.1155/2011/654746.

  • 6.

    Ogunyinka IA, Oshikoya KA, Olowo-okere A, Lukong CS, Adamaigbo C, Adebayo AA. Appropriateness of postoperative analgesic doses among pediatric surgical patients in a teaching hospital in Northwest Nigeria. Drugs Ther Perspect. 2019;35(3):135-44. https://doi.org/10.1007/s40267-019-00604-0.

  • 7.

    Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken). 2011;63 Suppl 11:S240-52. [PubMed ID: 22588748]. https://doi.org/10.1002/acr.20543.

  • 8.

    Tse MM, Ho SS. Enhancing knowledge and attitudes in pain management: a pain management education program for nursing home staff. Pain Manag Nurs. 2014;15(1):2-11. [PubMed ID: 24602419]. https://doi.org/10.1016/j.pmn.2012.03.009.

  • 9.

    Matthews E, Malcolm C. Nurses’ knowledge and attitudes in pain management practice. Br J Nurs. 2007;16(3):174-9. https://doi.org/10.12968/bjon.2007.16.3.22972.

  • 10.

    Scascighini L, Toma V, Dober-Spielmann S, Sprott H. Multidisciplinary treatment for chronic pain: a systematic review of interventions and outcomes. Rheumatology (Oxford). 2008;47(5):670-8. [PubMed ID: 18375406]. https://doi.org/10.1093/rheumatology/ken021.

  • 11.

    Urits I, Gress K, Charipova K, Habib K, Lee D, Lee C, et al. Use of cannabidiol (CBD) for the treatment of chronic pain. Best Pract Res Clin Anaesthesiol. 2020;34(3):463-77. [PubMed ID: 33004159]. https://doi.org/10.1016/j.bpa.2020.06.004.

  • 12.

    Aviram J, Pud D, Gershoni T, Schiff-Keren B, Ogintz M, Vulfsons S, et al. Medical cannabis treatment for chronic pain: Outcomes and prediction of response. Eur J Pain. 2021;25(2):359-74. [PubMed ID: 33065768]. https://doi.org/10.1002/ejp.1675.

  • 13.

    Longo R, Oudshoorn A, Befus D. Cannabis for Chronic Pain: A Rapid Systematic Review of Randomized Control Trials. Pain Manag Nurs. 2021;22(2):141-9. [PubMed ID: 33353819]. https://doi.org/10.1016/j.pmn.2020.11.006.

  • 14.

    Pramesh CS, Badwe RA, Borthakur BB, Chandra M, Raj EH, Kannan T, et al. Delivery of affordable and equitable cancer care in India. Lancet Oncol. 2014;15(6):e223-33. [PubMed ID: 24731888]. https://doi.org/10.1016/S1470-2045(14)70117-2.

  • 15.

    Olayemi O, Morhason-Bello IO, Adedokun BO, Ojengbede OA. The role of ethnicity on pain perception in labor among parturients at the University College Hospital Ibadan. J Obstet Gynaecol Res. 2009;35(2):277-81. [PubMed ID: 19335796]. https://doi.org/10.1111/j.1447-0756.2008.00937.x.

  • 16.

    Geurts JW, Willems PC, Lockwood C, van Kleef M, Kleijnen J, Dirksen C. Patient expectations for management of chronic non-cancer pain: A systematic review. Health Expect. 2017;20(6):1201-17. [PubMed ID: 28009082]. [PubMed Central ID: PMC5689237]. https://doi.org/10.1111/hex.12527.

  • 17.

    Worl Health Organization. Access to Controlled Medications Programme: improving access to medications under international drug conventions. Briefing note. Geneva: WHO; 2009.

  • 18.

    Cleary J, Powell RA, Munene G, Mwangi-Powell FN, Luyirika E, Kiyange F, et al. Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Africa: a report from the Global Opioid Policy Initiative (GOPI). Ann Oncol. 2013;24 Suppl 11:xi14-23. [PubMed ID: 24285225]. https://doi.org/10.1093/annonc/mdt499.

  • 19.

    Size M, Soyannwo OA, Justins DM. Pain management in developing countries. Anaesthesia. 2007;62 Suppl 1:38-43. [PubMed ID: 17937712]. https://doi.org/10.1111/j.1365-2044.2007.05296.x.

  • 20.

    Brennan F, Carr DB, Cousins M. Pain management: a fundamental human right. Anesth Analg. 2007;105(1):205-21. [PubMed ID: 17578977]. https://doi.org/10.1213/01.ane.0000268145.52345.55.

  • 21.

    De Lima L, Sweeney C, Palmer JL, Bruera E. Potent analgesics are more expensive for patients in developing countries: a comparative study. J Pain Palliat Care Pharmacother. 2004;18(1):59-70. [PubMed ID: 15148009].

  • 22.

    Seya MJ, Gelders SF, Achara OU, Milani B, Scholten WK. A first comparison between the consumption of and the need for opioid analgesics at country, regional, and global levels. J Pain Palliat Care Pharmacother. 2011;25(1):6-18. [PubMed ID: 21426212]. https://doi.org/10.3109/15360288.2010.536307.

  • 23.

    Jackson T, Thomas S, Stabile V, Shotwell M, Han X, McQueen K. A Systematic Review and Meta-Analysis of the Global Burden of Chronic Pain Without Clear Etiology in Low- and Middle-Income Countries: Trends in Heterogeneous Data and a Proposal for New Assessment Methods. Anesth Analg. 2016;123(3):739-48. [PubMed ID: 27537761]. https://doi.org/10.1213/ANE.0000000000001389.